Benefits for Physicians

RTsafe’s innovative technology brings you confidence and control across the entire treatment process. Confirmation of prescribed doses in a simulated environment verifies the efficacy of your plans ahead of treatment execution. As a result, even your most demanding cases (such as multiple brain metastases) become easier to undertake.

Your ability to visualize a patient’s treatment through individualized simulation ensures the desired outcome while simultaneously minimizing the possibility of debilitating side effects. You have the option to share the simulation with the patient, and help them to understand the whole process. In this way, you can provide exceptional patient involvement and empowerment by offering compelling evidence of safe and accurate treatment ahead of a medical intervention.

Additionally, you can store data from the simulation in each patient’s medical record as
proof of good medical practice.

product_pseudopatient

PseudoPatient®

Patient Treatment Verification Redefined. Safety Personalized.

PseudoPatient® is an FDA cleared device constructed by the real patient’s CT data using highly accurate 3D printing technology. It forms an anatomically accurate replica of patient’s head, providing physicians and medical physicists with either direct dose measurements of anatomic regions of high interest (point, 2D), or a full relative 3D dose map, ideal for demanding SRS cases, such as small benign tumors.

Publications

  • Validation of optical surface/thermal imaging and X-ray positioning accuracy for SRS treatments

    Vanessa da Silva Mendes, Michael Reiner, Stefanie Corradini, Maximilian Niyazi, Claus Belka, Guillaume Landry, Philipp Freislederer ESTRO congress 2021, Madrid
  • Feasibility of spinal stereotactic body radiotherapy in Elekta Unity® MR-Linac

    Eun Young Han, Manik Aima, Neil Hughes, Tina M. Briere, Debra N. Yeboa, Pam Castillo, Jihong Wang, Jinzhong Yang, Sastry Vedam Journal of Radiosurgery and SBRT, (2020)

Request a quote

See Whats new at RTsafe

RTsafe receives grant under the Operational Program “Competitiveness, Entrepreneurship & Innovation” (EPAnEK), €100,000.00.

RTsafe receives grant under the Operational Program “Competitiveness, Entrepreneurship & Innovation” (EPAnEK), €100,000.00.

Announcements
Η RTsafe χρηματοδοτείται στο πλαίσιο του Επιχειρησιακού Προγράμματος «Ανταγωνιστικότητα, Επιχειρηματικότητα και Καινοτομία (ΕΠΑνΕΚ), μέσω της δράσης «Στήριξη Νεοφυών Επιχειρήσεων Εθνικού...
Read More
PseudoPatient Technology – A personalized pretreatment verification in SRS

PseudoPatient Technology – A personalized pretreatment verification in SRS

Announcements
Join our Webinar on September 28, 1:00 p.m. UK by Dr Georgios Kritselis, titled ‘’PseudoPatient Technology - A personalized pretreatment...
Read More
RTsafe and Biomedic Medical Group sign exclusive agreement for distribution

RTsafe and Biomedic Medical Group sign exclusive agreement for distribution

Announcements
RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions,...
Read More
ΕΣΠΑ Banner